Press releases

image of papers

Key Capital Strengthens Vaccine Patents

NEW YORK, NY, February 18, 2021 – KEY CAPITAL CORPORATION (OTC Pink: KCPC) advises that it continues to work with Immunitor, its partner and Licensor, to progress further research and development of its breakthrough therapeutic vaccines, and for several unique supplements.

Read More »